New Frontiers in Pathology GU case presentation - PowerPoint PPT Presentation

1 / 51
About This Presentation
Title:

New Frontiers in Pathology GU case presentation

Description:

New Frontiers in Pathology GU case presentation – PowerPoint PPT presentation

Number of Views:59
Avg rating:3.0/5.0
Slides: 52
Provided by: university57
Category:

less

Transcript and Presenter's Notes

Title: New Frontiers in Pathology GU case presentation


1
New Frontiers in PathologyGU case presentation
  • Rajal B. Shah, M.D.
  • Associate Professor - Pathology and Urology

2
Case 13
  • A 65 year-old white American male with serum PSA
    of 4 ng/ml, underwent extended 12 core biopsies

3
(No Transcript)
4
(No Transcript)
5
34ßE12 p63
6
P504S
7
P504S
8
Summary of atypical findings
  • Disorganized growth pattern
  • Presence of some round and poorly formed small
    glands
  • Micro nucleoli
  • Lack of basal cell staining in some glands
  • AMACR reactivity

9
Diagnosis
  • Benign prostate parenchyma with focus of partial
    atrophy

10
Diagnosis of Limited Cancer in Prostate Biopsy
Critical Issues
  • Recognize cancer and avoid under-diagnosis (false
    negative)
  • Recognize benign mimics and avoid over-diagnosis
    (false positive)

11
Mimics of Prostate Cancer
Pattern 1 Small glandular growth pattern
Pattern 2 Cribriform/large growth pattern
Pattern 3 Fused gland/solid growth pattern
12
Pattern 1-Small gland mimics
  • Seminal vesicle/ejaculatory duct epithelium
  • Cowpers glands
  • Verumontenum hyperplasia
  • Crowding of small glands
  • Mucinous metaplasia
  • Mesonephric gland hyperplasia
  • Post atrophic hyperplasia/atrophy
  • Partial atrophy
  • Adenosis
  • Radiation atypia
  • Nephrogenic adenoma
  • Basal cell hyperplasia

13
PA Among the most common reasons for second
opinion
Herawi M et al, AJSP, 2005
14
Partial atrophy (PA) - Background
  • Experts have utiized various terms to describe
    partial atrophy
  • Some have used the term post atrophic hyperplasia
    (PAH) to describe similar lesions
  • (Amin MB et al, 1999, Srigley JR et al, 2004)
  • Recently PA and PAH recognized as a distinct
    types of focal atrophy in the Working Group
    Classification of Focal Prostate Atrophy Lesions
    (De Marzo et al, 2006)

15
Partial atrophy - Significance
  • Potential for confusion with prostatic
    adenocarcinoma (PCa)
  • Among the most common reasons for second opinion
    in a consultation practice (Herawi et al, 2005)
  • Potential immunohistochemical (basal cell markers
    and P504S (monoclonal antibody to AMACR)) overlap
    with PCa
  • Association with inflammation and proliferation
    found in certain forms of atrophy such as post
    atrophic hyperplasia (Ruska et al, 1998 De Marzo
    et al, 1999 Shah R et al, 2001)

16
AJSP, 32(1), 2008
  • Architectural indices
  • Gland size
  • Gland shape
  • Circumscription
  • Stromal characteristics
  • Associated completely atrophic glands within the
    focus
  • Luminal secretions
  • Inflammation
  • Cytological indices
  • Character of cytoplasm
  • Nuclear size in relation to benign glands
  • Micronucleoli (visible only at 40x) and
    macronucleoli (visible easily at 10X)

17
AJSP, 32(1), 2008
  • Basal cell marker cocktail(34ßE12 p63)
  • Completely positive
  • Patchy positive
  • Completely negative
  • P504S - Rabbit monoclonal antibody to AMACR (Zeta
    corporation, Sierra Madre, CA )
  • Negative
  • Weak
  • Moderate-to-strong
  • (Expression evaluated in relation to benign
    glands)

18
Study design - Proliferation status
  • Ki-67 (MIB-1 clone) immunohistochemistry
  • Quantitative analysis by ChromaVision ACIS
  • Measurement of stain intensity of
  • PA foci compared with benign glands (range
    0-225, 0-100)
  • Manual delineation of foci

19
Results - Morphology (architectural features)
N73 foci
20
Circumscribed focus with stellate star shaped
glands
21
Disorganized poorly formed round glands
22
Results - Morphology (architectural features)
FEATURES
CASES
23
Complete dark atrophic glands within the focus
24
Results - Morphology (cytologic features)
FEATURES
CASES
25
Micro nucleoli visible at high power
26
  • Other benign conditions known to contain
    nucleoli
  • gt Basal cell hyperplasia
  • gt Post atrophic hyperplasia
  • gt Adenosis
  • gt Radiation atypia
  • gt Benign glands associated with
    inflammation

27
Clear cytoplasm similar to adjacent benign
glands, placed laterally to Nuclei giving them
partially atrophic look
28
Results IHC Basal cell markers cocktail 34ßE12
p63
29
(No Transcript)
30
(No Transcript)
31
(No Transcript)
32
Other lesions with patchy/negative basal cell
reactions
  • PIN
  • Adenosis
  • Lack of basal cell staining in few atypical
    glands is not necessarily diagnostic of cancer

33
Results IHC P504S
34
Comparison with published literature
  • AMACR results
  • 79 (15/19 cases) (Herawi et al, 2005)
  • Series consisting of selected consultation cases
    with AMACR staining performed at multiple
    institutions
  • 31 (38/122 foci) (Adley et al, 2006)
  • Hospital based series, AMACR staining using the
    triple antibody (P504S CK 903 p63)

35
AMACR-specificity issues
PIN Prostatic intraepithelial neoplasia, NA
Nephrogenic adenoma NS Not studied
36
Results - Basal cell markers and P504S antibody
as a panel
37
Results - Proliferation status
  • N54 foci
  • Mean proliferative indices
  • PA foci5.5 (range 0-30)
  • Benign glands5.6 (range 0-31)
  • P0.97 (paired t-test)

38
Summary - Features that potentially mimic
prostate cancer
  • Morphology
  • Disorganized growth pattern
  • Small, round, poorly-formed glands
  • Visible nucleoli
  • Immunohistochemistry
  • Very patchy/negative staining for basal cells
  • Possible AMACR positivity

39
Summary - Reliable morphologic features of PA
  • Stellate/undulated gland lumina
  • Pale cytoplasm similar to adjacent benign glands
  • Presence of completely atrophic glands within the
    focus
  • Lack of nuclear enlargement or macronucleoli

40
Morphological low-power comparison of PAH and PA
PAH
PA
PAH post atrophic hyperplasia, PA partial
atrophy
41
So where to draw a line between partial atrophy
and atypia/cancer?
  • Infiltrative glands
  • Amphophilic cytoplasm
  • Macronucleoli
  • Presence of blue mucin
  • Lack of basal cell markers and/or AMACR
    positivity with any of the above features

42
Architectural/cytological features not specific
but suggest the benign diagnosis
43
Architecture Lobular/circumscribed growth
44
Pseudo infiltrative appearance patch like
growth pattern
45
Benign glands as reference Similar cytoplasmic
character
Benign gland
46
Cellular spindle cell stroma
BCH Adenosis Sclerosing adenosis
47
Complete atrophy BCH
Nuclei occupy full cell height
48
SV Radiation atypia
Random cytological atypia
49
Radiation atypia
Random cytological atypia, smudgy nuclei,
prominent nucleoli, cytoplasmic vacuolization
50
Conclusions
  • A systemic approach using constellation of
    architectural and cytological features necessary
    to work up atypical small glandular
    proliferations
  • Diagnosis relies on constellation of features
  • Use markers to support your impression, use them
    as a panel
  • An expert second opinion can help reduce atypia
    rate

51
Thank You
Write a Comment
User Comments (0)
About PowerShow.com